There is a potential role for the use of biomarkers in the diagnosis of cancer cachexia—human CC patients have been demonstrated to have elevated C-reactive protein (CRP), fibrinogen, IL1, IL6 and TNF-a [6,8]. This evidence concerns the gene IL6 and cancer.